Quaker Chemical Corporation (FRA:QUC)
Germany · Delayed Price · Currency is EUR 130.00
-6.00 (-4.41%)
At close: Jan 23, 2026
Quaker Chemical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,864 | 1,840 | 1,953 | 1,944 | 1,761 | 1,418 | |
Revenue Growth (YoY) | 0.08% | -5.82% | 0.50% | 10.36% | 24.23% | 25.07% |
Cost of Revenue | 1,188 | 1,154 | 1,248 | 1,331 | 1,165 | 903.21 |
Gross Profit | 676.07 | 686.03 | 705.64 | 612.65 | 596.14 | 514.47 |
Selling, General & Admin | 379.97 | 371.12 | 377.09 | 358.98 | 313.3 | 306.44 |
Research & Development | 57.3 | 57.3 | 50.3 | 46 | 44.9 | 40 |
Amortization of Goodwill & Intangibles | 58.2 | 58.2 | 58.2 | 57.5 | 59.9 | 55.9 |
Operating Expenses | 495.47 | 486.62 | 485.59 | 462.48 | 418.1 | 402.34 |
Operating Income | 180.6 | 199.41 | 220.05 | 150.17 | 178.04 | 112.13 |
Interest Expense | -43.26 | -44.64 | -55 | -36.63 | -23.84 | -28.3 |
Interest & Investment Income | 2.91 | 3.63 | 4.3 | 4.05 | 1.51 | 1.7 |
Earnings From Equity Investments | 16.29 | 10.97 | 15.33 | 1.97 | 9.38 | 7.35 |
Currency Exchange Gain (Loss) | -4.22 | -0.98 | -6.99 | -7.8 | -3.22 | -5.68 |
Other Non Operating Income (Expenses) | 2.68 | 4.79 | 2.7 | -0.12 | 17.22 | 4.78 |
EBT Excluding Unusual Items | 155 | 173.19 | 180.4 | 111.64 | 179.09 | 91.98 |
Merger & Restructuring Charges | -40.57 | -6.53 | -7.59 | -3.16 | -21.42 | -36.96 |
Gain (Loss) on Sale of Assets | -0.2 | 0.81 | 1.31 | 0.17 | -0.71 | -0.27 |
Asset Writedown | - | - | - | -93 | - | -38 |
Other Unusual Items | -3.23 | -2.44 | -7.8 | -8.36 | -0.6 | -0.4 |
Pretax Income | 22.16 | 166.03 | 168.46 | 9.08 | 156.37 | 34.49 |
Income Tax Expense | 31.13 | 49.3 | 55.59 | 24.93 | 34.94 | -5.3 |
Earnings From Continuing Operations | -8.97 | 116.73 | 112.87 | -15.84 | 121.43 | 39.79 |
Minority Interest in Earnings | -0.03 | -0.09 | -0.12 | -0.09 | -0.06 | -0.13 |
Net Income | -9 | 116.64 | 112.75 | -15.93 | 121.37 | 39.66 |
Preferred Dividends & Other Adjustments | 0.06 | 0.38 | 0.56 | -0.09 | 0.48 | 0.15 |
Net Income to Common | -9.06 | 116.27 | 112.19 | -15.84 | 120.89 | 39.51 |
Net Income Growth | - | 3.45% | - | - | 206.04% | 25.41% |
Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 | 18 |
Shares Change (YoY) | -1.90% | -0.25% | 0.33% | 0.01% | 0.59% | 17.07% |
EPS (Basic) | -0.52 | 6.51 | 6.27 | -0.89 | 6.79 | 2.23 |
EPS (Diluted) | -0.52 | 6.51 | 6.26 | -0.89 | 6.77 | 2.22 |
EPS Growth | - | 3.95% | - | - | 204.98% | 6.73% |
Free Cash Flow | 96.89 | 162.78 | 240.22 | 13.26 | 27.48 | 160.49 |
Free Cash Flow Per Share | 5.51 | 9.11 | 13.41 | 0.74 | 1.54 | 9.04 |
Dividend Per Share | 1.963 | 1.880 | 1.780 | 1.700 | 1.620 | 1.560 |
Dividend Growth | 6.11% | 5.62% | 4.71% | 4.94% | 3.85% | 2.30% |
Gross Margin | 36.27% | 37.29% | 36.13% | 31.52% | 33.85% | 36.29% |
Operating Margin | 9.69% | 10.84% | 11.27% | 7.73% | 10.11% | 7.91% |
Profit Margin | -0.49% | 6.32% | 5.74% | -0.81% | 6.86% | 2.79% |
Free Cash Flow Margin | 5.20% | 8.85% | 12.30% | 0.68% | 1.56% | 11.32% |
EBITDA | 270.03 | 283.53 | 302.04 | 230.64 | 263.89 | 194.57 |
EBITDA Margin | 14.49% | 15.41% | 15.46% | 11.87% | 14.98% | 13.73% |
D&A For EBITDA | 89.43 | 84.12 | 81.99 | 80.47 | 85.85 | 82.45 |
EBIT | 180.6 | 199.41 | 220.05 | 150.17 | 178.04 | 112.13 |
EBIT Margin | 9.69% | 10.84% | 11.27% | 7.73% | 10.11% | 7.91% |
Effective Tax Rate | 140.49% | 29.69% | 33.00% | 274.41% | 22.34% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.